PYC Therapeutics Ltd (PYC)

Sydney
Currency in AUD
1.065
+0.010(+0.95%)
Closed
PYC Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
1.0301.085
52 wk Range
0.7212.100
Key Statistics
Edit
Bid/Ask
1.04 / 1.10
Prev. Close
1.055
Open
1.05
Day's Range
1.03-1.085
52 wk Range
0.721-2.1
Volume
203.78K
Average Volume (3m)
355.43K
1-Year Change
28.3%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PYC Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
8.751
Upside
+721.66%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory
Show more

PYC Therapeutics Ltd Company Profile

PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia. The company offers VP-001, a drug program which is Phase 1 clinical trial for the treatment of retinitis pigmentosa type 11; PYC-001, a drug candidate for the treatment of blinding eye disease; PYC-002 a drug program for the treatment of a severe neurodevelopmental disorder; and PYC-003, which is indicated to treat autosomal dominant polycystic kidney disease. PYC Therapeutics Limited has academic-industry collaborations with Murdoch University to support drug discovery and development efforts in the field of neurodegenerative disorders. The company was formerly known as Phylogica Limited and changed its name to PYC Therapeutics Limited in November 2019. PYC Therapeutics Limited was incorporated in 2001 and is based in Nedlands, Australia.

Compare PYC to Peers and Sector

Metrics to compare
PYC
Peers
Sector
Relationship
P/E Ratio
−13.2x−2.5x−0.6x
PEG Ratio
0.37−0.050.00
Price/Book
6.2x2.1x2.6x
Price / LTM Sales
22.5x9.6x3.1x
Upside (Analyst Target)
289.8%172.4%51.3%
Fair Value Upside
Unlock−0.8%7.3%Unlock

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 8.751
(+721.66% Upside)

Earnings

Latest Release
Feb 28, 2023
EPS / Forecast
-0.01 / --
Revenue / Forecast
3.49M / --
EPS Revisions
Last 90 days

FAQ

What Is the PYC Therapeutics Ltd (PYC) Stock Price Today?

The PYC Therapeutics Ltd stock price today is 1.065

What Stock Exchange Does PYC Therapeutics Ltd Trade On?

PYC Therapeutics Ltd is listed and trades on the Sydney stock exchange.

What Is the Stock Symbol for PYC Therapeutics Ltd?

The stock symbol for PYC Therapeutics Ltd is "PYC."

What Is the PYC Therapeutics Ltd Market Cap?

As of today, PYC Therapeutics Ltd market cap is 496.94M.

What is PYC Therapeutics Ltd Earnings Per Share?

The PYC Therapeutics Ltd EPS is -0.096.

From a Technical Analysis Perspective, Is PYC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.